Emerging research are generating significant interest around retatrutide, a innovative drug demonstrating remarkable results in weight regulation. This molecule combines the actions of a hormone receptor agonist and a gut-dependent insulinotropic hormone , seemingly offering a synergistic method to tackling obesity and linked metabolic conditions